Clinical trials: Irreversible Vision Loss
Irreversible Vision Loss
Meta Glasses for Low Vision
Visual impairment, particularly from glaucoma and retinal dystrophies, significantly hinders mobility and increases the risk of falls, leading to decreased independence and mental health challenges.
- Trial name
- NCT07317180
- Testing
- Meta AI Glasses, Control
- Volunteers
- 50 people
- Sponsor
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's